The patient, a 58-year-old woman, had suffered from excessive bleeding since early childhood. The coagulation studies were diagnostic of Glanzmann's thrombasthenia with diminished platelet aggregation in response to ristocetin (table Intravenous transfusion of platelets from random and from selected donors had no effect on the bleeding time or the platelet count, nor did six units of platelets from selected donors injected through an intra-arterial catheter into the right renal artery. The patient apparently had antibodies against HLA antigens and platelet-specific antibodies against the Zwa antigen. Only a very small amount of the Zwa antigen could be detected on her platelets (Van Leeuwen EF et al, unpublished observations). To stop the bleeding it was decided to perform an arterial catheter embolisation of the kidney, because the haemorrhagic diathesis precluded nephrectomy. Fourteen weeks after the bleeding began the two branches of the right renal artery were occluded via a percutaneous arterial catheterisation by means of the coils of Gianturco and Wallace.' For six days afterwards the patient had severe pain in the flank and fever. The haematuria decreased gradually, and 10 days after the procedure the urinary sediment contained only sporadic red cells per high-power field. There were also transient rises of the serum creatinine concentration, the lactic dehydrogenase fractions 1 and 2, and the transaminase activities. Mild hypertension ensued, which was controlled by propranolol. Now, two years later, the patient is fit.
Comment
Despite careful selection by HLA typing and platelet fluorescence tests, we did not find any donor whose platelets were effective in the circulation of this patient. Anti-Zwa antibodies3 destroyed the transfused platelets. Therefore transcatheter embolisation was considered to be the only reasonable means of treatment. There was a risk, however, that bleeding would continue from capsular vessels or possibly from the necrotic kidney.
The case shows that transcatheter embolisation of a renal artery may be life saving in a patient who has a severe defect in the primary phase of haemostasis and is resistant to conventional treatment. Whether this applies equally to patients with coagulation defects (for example, haemophiliacs with an antibody against the missing clotting factor) is doubtful. In contrast to patients with thrombocytosis spontaneous intraparenchymal bleeding is well known in patients with severe coagulopathy. In such patients the risk of haemorrhage from the necrotic kidney is apparently much greater than in platelet disorders. Recently, however, the procedure has been successful in a patient with haemophilia A and posttraumatic renal bleeding.4
We thank Professor H C Nieweg, University Hospital, Groningen, for permission to publish this case. He referred the patient to us because HLA-identical platelet donors were available in Leiden. Drugs that affect the mind often also lead to a change in weight, whether a loss after amphetamines or a gain after lithium.' The benzodiazepines, the drugs most commonly prescribed as hypnotics and for the relief of anxiety, have been thought to cause weight gain,' as they do in many animals.3 We have therefore examined data from a recent study, conducted for other purposes, in which the effects of the drug would have been uncontaminated by effects that might themselves have been a consequence of symptoms such as anxiety and in which seasonal effects were controlled for by a group who during the same months were taking placebos. 
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